SCHEMBL7403199

SCHEMBL7403199

O=C(CC1OCCc2cc(Br)ccc21)N1CCN(c2ccc(F)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.51
DRD2 P14416 4/20 0.48
HTR2A P28223 4/20 0.48
HTR1A P08908 4/20 0.48
DRD4 P21917 2/20 0.48
ADRA2A P08913 1/20 0.48
ADRA2B P18089 1/20 0.48
ADRA2C P18825 1/20 0.48
DRD1 P21728 1/20 0.48
ADRA1D P25100 1/20 0.48
ADRA1A P35348 1/20 0.48
ADRA1B P35368 1/20 0.48
DRD3 P35462 1/20 0.48
HTR2B P41595 1/20 0.48
HTR1D P28221 6/20 0.47
SLC6A4 P31645 2/20 0.47
EIF4H Q15056 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
POLB P06746 1/20 0.45
AKR1C3 P42330 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7398102 0.90 HTR1D (0.44) MAPTDRD2HTR2AHTR1ADRD4
SCHEMBL7404888 0.90 AKR1C3 (0.46) MAPTDRD2HTR2AHTR1ADRD4
SCHEMBL8592418 0.89 AKR1C3 (0.46) MAPTDRD2HTR2AHTR1ADRD4
SCHEMBL8592415 0.89 AKR1C3 (0.46) MAPTDRD2HTR2AHTR1ADRD4
SCHEMBL8591794 0.88 HTR1D (0.43) MAPTDRD2HTR2AHTR1ADRD4
SCHEMBL8591793 0.88 HTR1D (0.43) MAPTDRD2HTR2AHTR1ADRD4
SCHEMBL8591792 0.87 DRD2 (0.57) MAPTDRD2HTR2AHTR1ADRD4
SCHEMBL8590585 0.87 DRD2 (0.57) MAPTDRD2HTR2AHTR1ADRD4
SCHEMBL8590591 0.87 DRD2 (0.57) MAPTDRD2HTR2AHTR1ADRD4
SCHEMBL8592054 0.87 HTR1D (0.45) MAPTDRD2HTR2AHTR1ADRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed